Cost-effectiveness of sofosbuvir-based treatments for chronic hepatitis C in the US

BMC Gastroenterology

Table 7 Health-state specific QALYs

QALYs	Baseline	Range	Reference
Uninfected	1	1	[27]
Chronic Hepatitis C	0.82	0.6-0.9	[27]
Compensated Cirrhosis	0.78	0.5-0.9	[27]
Decompensated Cirrhosis	0.65	0.3-0.88	[27]
HCC	0.25	0.1-0.5	[27]
Liver Transplant (1st year)	0.5	0.11-0.7	[27]
Liver Transplant (successive year)	0.7	0.24-0.87	[27]

ISSN: 1471-230X